What does CUSIP 68235M105 represent in this 13F holders report?

CUSIP 68235M105 is the security identifier for ONS - ONCOBIOLOGICS INC - COM used to aggregate holder disclosures.

How many institutions held ONS - ONCOBIOLOGICS INC - COM in Q2 2018?

11 institutional investors reported ONS - ONCOBIOLOGICS INC - COM for Q2 2018. Use the holders table for investor-level position and value details.

ONCOBIOLOGICS INC - COM (ONS)

CUSIP: 68235M105

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / COM
Total 13F shares: 5,106,341
Share change: +1,377,149
Total reported value: $4,313,000
Price per share: $0.84
Number of holders: 11
Value change: +$1,154,697
Number of buys: 2
Number of sells: 7

Quarterly Holders Quick Answers

What is CUSIP 68235M105?
CUSIP 68235M105 identifies ONS - ONCOBIOLOGICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of ONCOBIOLOGICS INC - COM (ONS) as of Q2 2018

As of 30 Jun 2018, ONCOBIOLOGICS INC - COM (ONS) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,106,341 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, venBio Select Advisor LLC, VANGUARD GROUP INC, Marshall Wace North America L.P., PANAGORA ASSET MANAGEMENT INC, ACUTA CAPITAL PARTNERS, LLC, TWO SIGMA SECURITIES, LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, and UBS Group AG. This page lists 11 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.